# Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort

> **NCT06967428** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Independent Medical Alliance** · enrollment: 100 (estimated)

## Conditions studied

- Vaccine Adverse Reaction
- Post Acute Covid-19 Vaccination Syndrome

## Interventions

- **COMBINATION_PRODUCT:** Combined metabolic modulator
- **DIETARY_SUPPLEMENT:** Rice Protein Powder with Vitamin C

## Key facts

- **NCT ID:** NCT06967428
- **Lead sponsor:** Independent Medical Alliance
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2026-01
- **Final completion:** 2026-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967428, "Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06967428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*